펩티드 치료제 시장은 2023-20281년에 178억 5,000만 달러, 예측 기간 중 CAGR은 10.03%로 성장할 것으로 예측됩니다.
펩티드 치료제 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 감염증 유행의 증가, 유리한 상환 정책의 이용 가능성 및 반감기가 연장된 약제에 의해 촉진되고 있습니다.
| 시장 범위 |
| 기준년 |
2024 |
| 종료년 |
2028 |
| 예측 기간 |
2024-2028 |
| 성장 모멘텀 |
가속 |
| 전년대비 2024년 |
8.88% |
| CAGR |
10.03% |
| 증분액 |
178억 5,000만 달러 |
본 조사에서는 향후 수년간 펩티드 치료제 시장 성장을 촉진하는 주요 요인의 하나로 연구개발을 위한 공동 연구를 들고 있습니다. 또한 펩티드 치료제의 강력한 파이프라인과 신기술의 출현은 시장의 큰 수요로 연결됩니다.
목차
제1장 개요
제2장 시장 구도
제3장 시장 규모 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2023
- 시장 전망 2023-2028
제4장 시장 규모 실적
- 세계의 펩티드 치료제 시장 2018-2022
- 투여 경로별 부문 분석 2018-2022
- 지역별 부문 분석 2018-2022
- 국가별 부문 분석 2018-2022
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제6장 시장 세분화 : 투여 경로별
- 시장 세분화
- 비교 : 투여 경로별
- 비경구 : 시장 규모와 예측 2023-2028
- 경구 : 시장 규모와 예측 2023-2028
- 기타 : 시장 규모와 예측 2023-2028
- 시장 기회 : 투여 경로별
제7장 고객 상황
제8장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2023-2028
- 유럽 : 시장 규모와 예측 2023-2028
- 아시아 : 시장 규모와 예측 2023-2028
- 세계의 기타 지역 : 시장 규모와 예측 2023-2028
- 미국 : 시장 규모와 예측 2023-2028
- 독일 : 시장 규모와 예측 2023-2028
- 중국 : 시장 규모와 예측 2023-2028
- 영국 : 시장 규모와 예측 2023-2028
- 캐나다 : 시장 규모와 예측 2023-2028
- 시장 기회 : 지역별
제9장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제10장 경쟁 구도
제11장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Amgen Inc.
- AstraZeneca Plc
- Eli Lilly and Co.
- Ever Pharma
- GlaxoSmithKline Plc
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
제12장 부록
KSA
The peptide therapeutics market is forecasted to grow by USD 17.85 bn during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the peptide therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of infectious diseases, availability of favorable reimbursement policies, and drugs with extended half-life.
Technavio's peptide therapeutics market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 8.88% |
| CAGR | 10.03% |
| Incremental Value | $17.85bn |
By Route Of Administration
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the collaborations for r and d as one of the prime reasons driving the peptide therapeutics market growth during the next few years. Also, strong pipeline of peptide therapeutics and advent of novel technologies will lead to sizable demand in the market.
The report on the peptide therapeutics market covers the following areas:
- Peptide therapeutics market sizing
- Peptide therapeutics market forecast
- Peptide therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peptide therapeutics market vendors that include Almac Group Ltd., AmbioPharm Inc., Amgen Inc., AstraZeneca Plc, Bachem AG, Bristol Myers Squibb Co., Corden Pharma International GmbH, Eli Lilly and Co., Ever Pharma, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Ipsen Pharma, Lonza Group Ltd., Novartis AG, Novo Nordisk AS, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Worg pharma. Also, the peptide therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Peptide Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Peptide Therapeutics Market 2018 - 2022 ($ billion)
- 4.2 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
- 4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- 4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Route of Administration
- 6.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)
- 6.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 6.3 Parenteral - Market size and forecast 2023-2028
- Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
- Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
- Chart on Parenteral - Year-over-year growth 2023-2028 (%)
- Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
- 6.4 Oral - Market size and forecast 2023-2028
- Chart on Oral - Market size and forecast 2023-2028 ($ billion)
- Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
- Chart on Oral - Year-over-year growth 2023-2028 (%)
- Data Table on Oral - Year-over-year growth 2023-2028 (%)
- 6.5 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ billion)
- Data Table on Market opportunity by Route of Administration ($ billion)
7 Customer Landscape
- 7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
- 8.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 8.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 8.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 8.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 8.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 8.12 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
9 Drivers, Challenges, and Opportunity/Restraints
- 9.1 Market drivers
- 9.2 Market challenges
- 9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 9.4 Market opportunities/restraints
10 Competitive Landscape
- 10.1 Overview
- 10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 10.3 Landscape disruption
- Overview on factors of disruption
- 10.4 Industry risks
- Impact of key risks on business
11 Competitive Analysis
- 11.1 Companies profiled
- 11.2 Market positioning of companies
- Matrix on companies position and classification
- 11.3 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- 11.4 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- 11.5 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
- 11.6 Ever Pharma
- Ever Pharma - Overview
- Ever Pharma - Product / Service
- Ever Pharma - Key offerings
- 11.7 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- 11.8 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 11.9 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key news
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- 11.10 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- 11.11 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- 11.12 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- 11.13 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
12 Appendix
- 12.1 Scope of the report
- 12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 12.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 12.4 Research methodology
- 12.5 Data procurement
- 12.6 Data validation
- 12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 12.8 Data synthesis
- 12.9 360 degree market analysis
- 360 degree market analysis
- 12.10 List of abbreviations
